JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 4134
CAS [1260907-17-2]
MF C22H22ClN5O2MW 423.90
I-BET762 is a cell-permeable benzodiazepine-based inhibitor of BET (bromodomain and extra terminal domain) proteins, BRD2, BRD3 and BRD4, binds to the tandem bromodomains of BET with Kd of 50.5–61.3 nM, displacing a tetra-acetylated H4 peptide prebound to tandem bromodomains of BET with IC50 of 32.5–42.5 nM in FRET analysis. I-BET-762 occupies the acetyl-lysine binding pocket of BET proteins and inhibits binding of BET proteins to acetylated histones, thus disrupts the formation of the chromatin complexes essential for expression of inflammatory genes.
Keywords: I-BET762 | Supplier | BET bromodomain inhibitor | Molibresib | GSK525762 | I-BET 762 | I-BET-762 | GSK-525762 | GSK 525762 | CT-BET762 | CAS [1260907-17-2] | Histone | BET (BRD) | Inhibitor | Proteins
(S)-2-(6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide
[1260907-17-2]
Potent and selective BET bromodomain inhibitor
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields